BioMérieux Reports 21 Percent Revenue Growth in Q4

NEW YORK – BioMérieux reported Wednesday that its fourth quarter revenues rose 21 percent year over year.

For the three months ended Dec. 31, BioMérieux reported revenues of €852.6 million ($908.2 million), up 14 percent on a reported basis, or 21 percent at constant exchange rates and scope of consolidation, from €746.8 million in the prior-year period.